Roelof Rongen
Overview
Roelof Rongen received an average of $796K in total compensation, including $290K in salary, at Matinas BioPharma Holdings from 2014 to 2018.
2018Matinas BioPharma HoldingsFormer Chief Executive Officer
2017Matinas BioPharma HoldingsFormer Chief Executive Officer
2016Matinas BioPharma HoldingsChief Executive Officer
2015Matinas BioPharma HoldingsChief Executive Officer
2014Matinas BioPharma HoldingsChief Executive Officer
Source: SEC filings on September 24, 2019, September 24, 2018, September 14, 2017, and September 22, 2016.
Related executives
We found six more executives who work or worked at Matinas BioPharma Holdings.
Jerome Jabbour
Matinas BioPharma Holdings
Chief Executive Officer
Raphael Mannino
Matinas BioPharma Holdings
Chief Scientific Officer
Gary Gaglione
Matinas BioPharma Holdings
Chief Financial Officer
Dominick DiPaolo
Matinas BioPharma Holdings
Former Senior Vice President, Quality and Regulatory Compliance
Douglas Kling
Matinas BioPharma Holdings
Senior Vice President, Clinical Development & Project Management
Abdel Fawzy
Matinas BioPharma Holdings